Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

A man developed alopecia areata after starting cancer treatment with vandetanib.

rTMS may help treat trichotillomania in some patients.

Ondansetron can cause serious allergic reactions, so use it carefully.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The treatment was not recommended due to limited effectiveness and significant side effects.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Oral minoxidil 7.5 mg for hair loss increases heart rate but not blood pressure.

Hyperthyroidism mostly affects young women and can cause heart issues, but these can improve with treatment.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

Traditional methods may not fully capture how the brain and breathing systems respond to carbon dioxide changes.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Ritlecitinib is safe and may effectively treat alopecia areata.

An elderly Chinese man lost all his hair after taking a new heart medication.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.